Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Duloxetine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 09 Oct 2008 Checked against the ClinicalTrials.gov record.
- 19 Aug 2008 Interim results presented at the 12th World Congress on Pain, according to a Boehringer Ingelheim media release.
- 20 Dec 2007 Status changed from in progress to completed.